TY - JOUR
T1 - Efficacy of immune checkpoint inhibitors in different types of melanoma
AU - Rossi, Ernesto
AU - Schinzari, Giovanni
AU - Maiorano, Brigida Anna
AU - Indellicati, Giulia
AU - Di Stefani, Alessandro
AU - Pagliara, Monica Maria
AU - Fragomeni, Simona Maria
AU - De Luca, Erika Valentina
AU - Sammarco, Maria Grazia
AU - Garganese, Giorgia
AU - Galli, Jacopo
AU - Blasi, Maria Antonietta
AU - Paludetti, Gaetano
AU - Scambia, Giovanni
AU - Peris, Ketty
AU - Tortora, Giampaolo
PY - 2020
Y1 - 2020
N2 - Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
AB - Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
KW - Immunotherapy
KW - conjunctival melanoma
KW - melanoma
KW - uveal melanoma
KW - Immunotherapy
KW - conjunctival melanoma
KW - melanoma
KW - uveal melanoma
UR - http://hdl.handle.net/10807/168629
U2 - 10.1080/21645515.2020.1771986
DO - 10.1080/21645515.2020.1771986
M3 - Article
SN - 2164-5515
VL - 17
SP - 1
EP - 10
JO - HUMAN VACCINES & IMMUNOTHERAPEUTICS
JF - HUMAN VACCINES & IMMUNOTHERAPEUTICS
ER -